stoxline Quote Chart Rank Option Currency Glossary
  
Cerenome, Inc. (CNSY)
0.6202  -0.095 (-13.23%)    11-17 13:34
Open: 0.7083
High: 0.7083
Volume: 185,188
  
Pre. Close: 0.7148
Low: 0.6006
Market Cap: 5(M)
Technical analysis
2026-11-17 1:13:52 PM
Short term     
Mid term     
Targets 6-month :  3.25 1-year :  4.96
Resists First :  2.79 Second :  4.25
Pivot price 1.03
Supports First :  0.42 Second :  0.35
MAs MA(5) :  0.77 MA(20) :  1.19
MA(100) :  2.61 MA(250) :  5.92
MACD MACD :  -0.4 Signal :  -0.3
%K %D K(14,3) :  8.7 D(3) :  9.8
RSI RSI(14): 30.6
52-week High :  19 Low :  0.42
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CNSY ] has closed above bottom band by 27.4%. Bollinger Bands are 96.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.99 - 0.99 0.99 - 1
Low: 0.67 - 0.68 0.68 - 0.68
Close: 0.71 - 0.72 0.72 - 0.72
Company Description

Cerenome, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Headline News

Mon, 16 Nov 2026
Cerenome, Inc. - Common Stock (Nasdaq:CNSY) Stock Quote - The Chronicle-Journal

Mon, 16 Nov 2026
Cerenome, Inc. (CNSY) Stock Price, News, Quote & History - Yahoo! Finance Canada

Mon, 16 Nov 2026
Cerenome Reports Interim ReSPECT-LM Data Supporting Repeat Dosing of REYOBIQ™ in Leptomeningeal Metastases at the 2026 SNO Annual Meeting - The Manila Times

Sat, 14 Nov 2026
Cerenome reports first CNSide revenue and details funding - Mugglehead Investment Magazine

Fri, 13 Nov 2026
Cerenome Reports Third-Quarter 2026 Results and Recent Business Progress, Expands CNSide Coverage and Advances REYOBIQ Trials - Quiver Quantitative

Fri, 13 Nov 2026
Cerenome (CNSY) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Pharmaceuticals
Shares Out 0 (M)
Shares Float 8 (M)
Held by Insiders 7.5e+006 (%)
Held by Institutions 1.9 (%)
Shares Short 652 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.595e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -2 %
Return on Assets (ttm) 203.6 %
Return on Equity (ttm) -135.4 %
Qtrly Rev. Growth 4.2e+006 %
Gross Profit (p.s.) -47.9
Sales Per Share -417.73
EBITDA (p.s.) -5.64626e+006
Qtrly Earnings Growth -3.4 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -22 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 2.4
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 1.23
Stock Dividends
Dividend 0
Forward Dividend 782150
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

Stoxline iOS

Alpha Bridge iOS

OptionCalc iOS

StockChart Android

Stoxline Android

Alpha Bridge Android

OptionCalc Android